BRIVIACT (UCB Australia Pty Ltd)
Product name
BRIVIACT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
196 working days (255)
Active ingredients
brivaracetam
Registration type
EOI
Indication
BRIVIACT (tablets and oral solution) are now also indicated as add-on therapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 4 years of age with epilepsy.